Hinge Health launching migraine treatment program, WSJ reports

Hinge Health (HNGE) is launching a program to treat and prevent migraine headaches, Connor Hart of Wall Steet Journal reports, citing an interview the company’s CEO Daniel Perez. “We started pulling on this thread a bit more, and what we saw is that migraine is a really big problem. We decided to not just incidentally treat migraine, but purposefully treat migraine,” Perez told the paper. Hinge’s program includes its wearable device Enso that delivers gentle electric pulses to reduce migraine pain, as well as trigger-tracking software and access to physical therapy, the Journal notes. Shares of Hinge are down 34c to $44.44 in early trading.